These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18607552)

  • 1. MDM2 mRNA expression in the p53 pathway may predict the potential of invasion and liver metastasis in colorectal cancer.
    Kondo I; Iida S; Takagi Y; Sugihara K
    Dis Colon Rectum; 2008 Sep; 51(9):1395-402. PubMed ID: 18607552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction of p53 pathway in human colorectal cancer: analysis of p53 gene mutation and the expression of the p53-associated factors p14ARF, p33ING1, p21WAF1 and MDM2.
    Tachibana M; Kawamata H; Fujimori T; Omotehara F; Horiuchi H; Ohkura Y; Igarashi S; Kotake K; Kubota K
    Int J Oncol; 2004 Oct; 25(4):913-20. PubMed ID: 15375540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer.
    Wang YC; Lin RK; Tan YH; Chen JT; Chen CY; Wang YC
    J Clin Oncol; 2005 Jan; 23(1):154-64. PubMed ID: 15625370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of the p14ARF-p53-MDM2 pathway in oral squamous cell carcinoma: MDM2 overexpression is a common event.
    Lim KP; Sharifah H; Lau SH; Teo SH; Cheong SC
    Oncol Rep; 2005 Oct; 14(4):963-8. PubMed ID: 16142358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer.
    Agrawal A; Yang J; Murphy RF; Agrawal DK
    Exp Mol Pathol; 2006 Oct; 81(2):115-22. PubMed ID: 16919268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different expression pattern and significance of p14ARF-Mdm2-p53 pathway and Bmi-1 exist between gastric cardia and distal gastric adenocarcinoma.
    Yao D; Wang Y; Xue L; Wang H; Zhang J; Zhang X
    Hum Pathol; 2013 May; 44(5):844-51. PubMed ID: 23159155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P14ARF deficiency and its correlation with overexpression of p53/MDM2 in sporadic vestibular schwannomas.
    Chen Y; Wang ZY; Wu H
    Eur Arch Otorhinolaryngol; 2015 Sep; 272(9):2227-34. PubMed ID: 24964769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Promoter Hypermethylation and Expression Profile of P14ARF and MDM2 Genes in Patients With Pterygium.
    Arish M; Kordi-Tamandani DM; Sangterash MH; Poyandeh R
    Eye Contact Lens; 2016 Jan; 42(1):e4-7. PubMed ID: 26020483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between p53-associated proteins and estrogen receptor status in ovarian serous neoplasms.
    Cho EY; Choi YL; Chae SW; Sohn JH; Ahn GH
    Int J Gynecol Cancer; 2006; 16(3):1000-6. PubMed ID: 16803476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma.
    Mori S; Ito G; Usami N; Yoshioka H; Ueda Y; Kodama Y; Takahashi M; Fong KM; Shimokata K; Sekido Y
    Cancer; 2004 Apr; 100(8):1673-82. PubMed ID: 15073856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of the MDM2-p73-P14ARF pathway related to tumour progression during urinary bladder carcinogenesis.
    Schlott T; Quentin T; Korabiowska M; Budd B; Kunze E
    Int J Mol Med; 2004 Nov; 14(5):825-36. PubMed ID: 15492852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53.
    Lindström MS; Klangby U; Wiman KG
    Oncogene; 2001 Apr; 20(17):2171-7. PubMed ID: 11360201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RT-PCR amplification of RNA extracted from formalin-fixed, paraffin-embedded oral cancer sections: analysis of p53 pathway.
    Tachibana M; Shinagawa Y; Kawamata H; Omotehara F; Horiuchi H; Ohkura Y; Kubota K; Imai Y; Fujibayashi T; Fujimori T
    Anticancer Res; 2003; 23(3C):2891-6. PubMed ID: 12926130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.
    Esteller M; Tortola S; Toyota M; Capella G; Peinado MA; Baylin SB; Herman JG
    Cancer Res; 2000 Jan; 60(1):129-33. PubMed ID: 10646864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2.
    Vestey SB; Sen C; Calder CJ; Perks CM; Pignatelli M; Winters ZE
    Breast Cancer Res; 2004; 6(5):R571-85. PubMed ID: 15318938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
    Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC
    Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse.
    Carr J; Bell E; Pearson AD; Kees UR; Beris H; Lunec J; Tweddle DA
    Cancer Res; 2006 Feb; 66(4):2138-45. PubMed ID: 16489014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line.
    Vaskivuo L; Rysä J; Koivuperä J; Myllynen P; Vaskivuo T; Chvalova K; Serpi R; Savolainen ER; Puistola U; Vähäkangas K
    Toxicol Appl Pharmacol; 2006 Oct; 216(1):89-97. PubMed ID: 16797627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p53/Mdm2/p14ARF cell cycle control pathway genes may be inactivated by genetic and epigenetic mechanisms in gliomas.
    Bello MJ; Rey JA
    Cancer Genet Cytogenet; 2006 Jan; 164(2):172-3. PubMed ID: 16434325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.